These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 34559138)
41. Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group. Sackmann M; Morgner A; Rudolph B; Neubauer A; Thiede C; Schulz H; Kraemer W; Boersch G; Rohde P; Seifert E; Stolte M; Bayerdoerffer E Gastroenterology; 1997 Oct; 113(4):1087-90. PubMed ID: 9322502 [TBL] [Abstract][Full Text] [Related]
42. Outcome of radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma refractory to Helicobacter pylori eradication therapy. Sugimoto M; Kajimura M; Shirai N; Furuta T; Kanaoka S; Ikuma M; Sato Y; Hishida A Intern Med; 2006; 45(6):405-9. PubMed ID: 16617193 [TBL] [Abstract][Full Text] [Related]
43. Involvement of non-Helicobacter pylori helicobacter infections in Helicobacter pylori-negative gastric MALT lymphoma pathogenesis and efficacy of eradication therapy. Takigawa H; Yuge R; Masaki S; Otani R; Kadota H; Naito T; Hayashi R; Urabe Y; Oka S; Tanaka S; Chayama K; Kitadai Y Gastric Cancer; 2021 Jul; 24(4):937-945. PubMed ID: 33638751 [TBL] [Abstract][Full Text] [Related]
44. The value of EUS in predicting the response of gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication. El-Zahabi LM; Jamali FR; El-Hajj II; Naja M; Salem Z; Shamseddine A; El-Saghir NS; Zaatari G; Geara F; Soweid AM Gastrointest Endosc; 2007 Jan; 65(1):89-96. PubMed ID: 17185085 [TBL] [Abstract][Full Text] [Related]
45. Helicobacter pylori and gastric lymphoma: high seroprevalence of CagA in diffuse large B-cell lymphoma but not in low-grade lymphoma of mucosa-associated lymphoid tissue type. Delchier JC; Lamarque D; Levy M; Tkoub EM; Copie-Bergman C; Deforges L; Chaumette MT; Haioun C Am J Gastroenterol; 2001 Aug; 96(8):2324-8. PubMed ID: 11513169 [TBL] [Abstract][Full Text] [Related]
47. Comparison of localized gastric mucosa-associated lymphoid tissue (MALT) lymphoma with and without Helicobacter pylori infection. Akamatsu T; Mochizuki T; Okiyama Y; Matsumoto A; Miyabayashi H; Ota H Helicobacter; 2006 Apr; 11(2):86-95. PubMed ID: 16579838 [TBL] [Abstract][Full Text] [Related]
48. Gastric low-grade B-cell MALT lymphoma: treatment, response, and genetic alteration. Nakamura T; Inagaki H; Seto M; Nakamura S J Gastroenterol; 2003; 38(10):921-9. PubMed ID: 14614598 [TBL] [Abstract][Full Text] [Related]
49. Commentary: role of Helicobacter pylori on gastric mucosal damage, gastric cancer, and gastric MALT lymphoma. Dixon MF Gastroenterology; 1997 Dec; 113(6 Suppl):S65-6. PubMed ID: 9394763 [No Abstract] [Full Text] [Related]
50. Consecutive regression of concurrent laryngeal and gastric MALT lymphoma after anti-Helicobacter pylori therapy. Caletti G; Togliani T; Fusaroli P; Sabattini E; Khodadadian E; Gamberi B; Gobbi M; Pileri S Gastroenterology; 2003 Feb; 124(2):537-43. PubMed ID: 12557157 [TBL] [Abstract][Full Text] [Related]
51. Helicobacter pylori Eradication Therapy Is Effective as the Initial Treatment for Patients with H. pylori-Negative and Disseminated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma. Gong EJ; Ahn JY; Jung HY; Park H; Ko YB; Na HK; Jung KW; Kim do H; Lee JH; Choi KD; Song HJ; Lee GH; Kim JH Gut Liver; 2016 Sep; 10(5):706-13. PubMed ID: 27114423 [TBL] [Abstract][Full Text] [Related]
52. Gastric MALT lymphoma: from concept to cure. Isaacson PG Ann Oncol; 1999 Jun; 10(6):637-45. PubMed ID: 10442184 [TBL] [Abstract][Full Text] [Related]
54. The Della Bella C; Soluri MF; Puccio S; Benagiano M; Grassi A; Bitetti J; Cianchi F; Sblattero D; Peano C; D'Elios MM Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502367 [TBL] [Abstract][Full Text] [Related]
55. Gastric mucosa-associated lymphoid tissue lymphomas and Helicobacter pylori infection: a Colombian perspective. Yepes S; Torres MM; Saavedra C; Andrade R World J Gastroenterol; 2012 Feb; 18(7):685-91. PubMed ID: 22363141 [TBL] [Abstract][Full Text] [Related]
56. Regression of low-grade gastric mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: possible association with p16 hypermethylation. Kim YS; Kim JS; Jung HC; Lee CH; Kim CW; Song IS; Kim CY J Gastroenterol; 2002 Jan; 37(1):17-22. PubMed ID: 11824795 [TBL] [Abstract][Full Text] [Related]
57. [Prognostic impact of Helicobacter pylori infection and eradication therapy in gastric mucosa-associated lymphoid tissue lymphoma]. Park SH; Chi HS; Park SJ; Jang S; Park CJ; Huh JR Korean J Lab Med; 2010 Dec; 30(6):547-53. PubMed ID: 21157137 [TBL] [Abstract][Full Text] [Related]
58. Prevention and treatment of low-grade B-cell primary gastric lymphoma by anti-H. pylori therapy. Cammarota G; Tursi A; Montalto M; Papa A; Branca G; Vecchio FM; Renzi C; VerzĂ A; Armuzzi A; Pretolani S J Clin Gastroenterol; 1995 Sep; 21(2):118-22. PubMed ID: 8583076 [TBL] [Abstract][Full Text] [Related]
59. Immunological and molecular analysis of B lymphocytes in low-grade MALT lymphoma of the stomach. Are there any useful markers for predicting outcome after Helicobacter pylori eradication? Matsushima Y; Kinoshita Y; Fukui H; Maekawa T; Yazumi S; Okada A; Nakase H; Kawanami C; Iwano M; Hashimoto K; Takeda Z; Okazaki K; Chiba T J Gastroenterol; 2002; 37(6):428-33. PubMed ID: 12108676 [TBL] [Abstract][Full Text] [Related]
60. The role of Helicobacter pylori eradication in the treatment of diffuse large B-cell and marginal zone lymphomas of the stomach. Ferreri AJ; Govi S; Ponzoni M Curr Opin Oncol; 2013 Sep; 25(5):470-9. PubMed ID: 23942292 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]